Sort
38,696 grants matching “als”
Functional & Structural Connectivity and Neuro Modulation in Alcohol Use Disorder
$1,063,137Abdolreza Momenan · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Neuroimaging of Alcohol Addiction
$1,063,137Abdolreza Momenan · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
NIRT: Merged CMOS/Molecular Integrated Circuit (Mol-MOS) Fabrication, Analysis and Design
$1,062,000Lloyd R Harriott · University Of Virginia Main Campus · · FY2002 · ENG
The TGF Beta Signaling Pathway in Development and Cancer
$1,062,000Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2020 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$1,062,000Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$1,062,000Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Absolute Quantification of Molecular Representation and Interaction
$1,061,393Aleksandra Nita-Lazar · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Dysregulation of Protein Synthesis in Fragile X Syndrome
$1,060,826Carolyn B. Smith · National Institute Of Mental Health · ZIA · FY2014 · MH
OXIDATIVE AND EXCITATORY TOXICITY IN NEURODEGENERATION
$1,060,670Massachusetts General Hospital · P01 · FY2003 · AG
Phylogenomic Studies on the Evolution of Morphological Complexity
$1,060,532Andreas Baxevanis · National Human Genome Research Institute · ZIA · FY2011 · HG
Neurobiological Basis of Neuronal Survival
$1,059,875Tsung Ping Su · National Institute On Drug Abuse · ZIA · FY2025 · DA
Randomized phase II study of TheraBionic in advanced hepatocellular carcinoma
$1,059,091Valerie Pasche · Therabionic Inc. · R44 · FY2021 · CA
Osteoarthritis: Prevention and Treatment
$1,058,781Thomas S Buchanan · University Of Delaware · P30 · FY2015 · GM
Developing novel LOX inhibitors to target chemotherapy resistant TNBC
$1,057,068Ozgur Sahin · Loxigen, Inc. · R42 · FY2025 · CA
REDUCING Risk &Enhancing Protective Factors in Children
$1,057,023University Of Washington · R01 · FY2002 · DA
FUNCTIONAL IMPROVEMENT BY ENHANCING PLASTICITY AND REINNERVATION IN ALS MOUSE MODEL
$1,056,725The Johns Hopkins University · · FY2019 · Department of the Army
Behavioral Health Collaborative for Rural American Indian Communities
$1,056,540John M. Roll · Washington State University · P20 · FY2013 · MD
Multimodal imaging: genetic and environmental effects in neuropsychiatry
$1,056,527Karen Faith Berman · National Institute Of Mental Health · ZIA · FY2014 · MH
MOLECULAR PATHOGENESIS OF CHROMOSOME 16 INVERSION INHUMAN LEUKEMIA
$1,056,349Paul Liu · National Human Genome Research Institute · ZIA · FY2010 · HG
An RNA topoisomerase complex interacts with Fragile X syndrome protein to promote neurodevelopment and maintain normal life-span
$1,055,262Weidong Wang · National Institute On Aging · ZIA · FY2018 · AG
CryoEM Data Collection Facility Consortium at NCMI
$1,054,750Wah Chiu · Baylor College Of Medicine · U24 · FY2016 · GM
Microphysiologial systems and low cost microfluidic platform with analytics
$1,054,728Michael L Shuler · Cornell University · UH2 · FY2013 · TR
Optimization of sigma-2 receptor modulators for the treatment of cognitive dysfunction
$1,054,468Nicholas John Izzo · Cognition Therapeutics, Inc. · R42 · FY2018 · AG
Study the pathogenesis of neurological disorders using human neural cultures derived from patient peripheral blood CD34 cells
$1,054,273Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Molecular Genetics Of Mammalian Retrovirus Replication
$1,053,638Judith G Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD